nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP1A2—Carmustine—lymphatic system cancer	0.0963	0.366	CbGbCtD
Mirtazapine—CYP2C9—Teniposide—lymphatic system cancer	0.0583	0.222	CbGbCtD
Mirtazapine—CYP3A4—Cytarabine—lymphatic system cancer	0.0344	0.131	CbGbCtD
Mirtazapine—CYP3A4—Teniposide—lymphatic system cancer	0.0339	0.129	CbGbCtD
Mirtazapine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0237	0.0902	CbGbCtD
Mirtazapine—CYP3A4—Vincristine—lymphatic system cancer	0.0163	0.0621	CbGbCtD
Mirtazapine—Mental disorder—Vincristine—lymphatic system cancer	0.000964	0.00131	CcSEcCtD
Mirtazapine—Chills—Mitoxantrone—lymphatic system cancer	0.000961	0.0013	CcSEcCtD
Mirtazapine—Bladder pain—Methotrexate—lymphatic system cancer	0.000961	0.0013	CcSEcCtD
Mirtazapine—Urine output increased—Methotrexate—lymphatic system cancer	0.000961	0.0013	CcSEcCtD
Mirtazapine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000961	0.0013	CcSEcCtD
Mirtazapine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000957	0.0013	CcSEcCtD
Mirtazapine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000947	0.00128	CcSEcCtD
Mirtazapine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000946	0.00128	CcSEcCtD
Mirtazapine—Confusional state—Bleomycin—lymphatic system cancer	0.000946	0.00128	CcSEcCtD
Mirtazapine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000942	0.00128	CcSEcCtD
Mirtazapine—Tremor—Carmustine—lymphatic system cancer	0.00094	0.00127	CcSEcCtD
Mirtazapine—Oedema—Bleomycin—lymphatic system cancer	0.000938	0.00127	CcSEcCtD
Mirtazapine—Infection—Bleomycin—lymphatic system cancer	0.000932	0.00126	CcSEcCtD
Mirtazapine—Anaemia—Carmustine—lymphatic system cancer	0.000927	0.00126	CcSEcCtD
Mirtazapine—Back pain—Vincristine—lymphatic system cancer	0.000926	0.00126	CcSEcCtD
Mirtazapine—Vomiting—Teniposide—lymphatic system cancer	0.000925	0.00126	CcSEcCtD
Mirtazapine—Agitation—Carmustine—lymphatic system cancer	0.000922	0.00125	CcSEcCtD
Mirtazapine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000918	0.00125	CcSEcCtD
Mirtazapine—Asthenia—Fludarabine—lymphatic system cancer	0.000918	0.00124	CcSEcCtD
Mirtazapine—Rash—Teniposide—lymphatic system cancer	0.000918	0.00124	CcSEcCtD
Mirtazapine—Dermatitis—Teniposide—lymphatic system cancer	0.000917	0.00124	CcSEcCtD
Mirtazapine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000913	0.00124	CcSEcCtD
Mirtazapine—Headache—Teniposide—lymphatic system cancer	0.000912	0.00124	CcSEcCtD
Mirtazapine—Pruritus—Fludarabine—lymphatic system cancer	0.000905	0.00123	CcSEcCtD
Mirtazapine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000904	0.00123	CcSEcCtD
Mirtazapine—Back pain—Mitoxantrone—lymphatic system cancer	0.000902	0.00122	CcSEcCtD
Mirtazapine—Leukopenia—Carmustine—lymphatic system cancer	0.000898	0.00122	CcSEcCtD
Mirtazapine—Anorexia—Bleomycin—lymphatic system cancer	0.000894	0.00121	CcSEcCtD
Mirtazapine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000887	0.0012	CcSEcCtD
Mirtazapine—Anaemia—Vincristine—lymphatic system cancer	0.000885	0.0012	CcSEcCtD
Mirtazapine—Agitation—Vincristine—lymphatic system cancer	0.00088	0.00119	CcSEcCtD
Mirtazapine—Polyuria—Methotrexate—lymphatic system cancer	0.000879	0.00119	CcSEcCtD
Mirtazapine—Hypotension—Bleomycin—lymphatic system cancer	0.000876	0.00119	CcSEcCtD
Mirtazapine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000875	0.00119	CcSEcCtD
Mirtazapine—Convulsion—Carmustine—lymphatic system cancer	0.000869	0.00118	CcSEcCtD
Mirtazapine—Hypertension—Carmustine—lymphatic system cancer	0.000866	0.00117	CcSEcCtD
Mirtazapine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000865	0.00117	CcSEcCtD
Mirtazapine—Nausea—Teniposide—lymphatic system cancer	0.000864	0.00117	CcSEcCtD
Mirtazapine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000862	0.00117	CcSEcCtD
Mirtazapine—Vertigo—Vincristine—lymphatic system cancer	0.00086	0.00117	CcSEcCtD
Mirtazapine—Leukopenia—Vincristine—lymphatic system cancer	0.000857	0.00116	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000854	0.00116	CcSEcCtD
Mirtazapine—Chest pain—Carmustine—lymphatic system cancer	0.000854	0.00116	CcSEcCtD
Mirtazapine—Myalgia—Carmustine—lymphatic system cancer	0.000854	0.00116	CcSEcCtD
Mirtazapine—Anxiety—Carmustine—lymphatic system cancer	0.000851	0.00115	CcSEcCtD
Mirtazapine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000842	0.00114	CcSEcCtD
Mirtazapine—Malaise—Mitoxantrone—lymphatic system cancer	0.000841	0.00114	CcSEcCtD
Mirtazapine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000836	0.00113	CcSEcCtD
Mirtazapine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000835	0.00113	CcSEcCtD
Mirtazapine—Convulsion—Vincristine—lymphatic system cancer	0.00083	0.00113	CcSEcCtD
Mirtazapine—Hypertension—Vincristine—lymphatic system cancer	0.000827	0.00112	CcSEcCtD
Mirtazapine—Confusional state—Carmustine—lymphatic system cancer	0.000825	0.00112	CcSEcCtD
Mirtazapine—Oedema—Carmustine—lymphatic system cancer	0.000819	0.00111	CcSEcCtD
Mirtazapine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000818	0.00111	CcSEcCtD
Mirtazapine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000815	0.00111	CcSEcCtD
Mirtazapine—Myalgia—Vincristine—lymphatic system cancer	0.000815	0.00111	CcSEcCtD
Mirtazapine—Cough—Mitoxantrone—lymphatic system cancer	0.000814	0.0011	CcSEcCtD
Mirtazapine—Infection—Carmustine—lymphatic system cancer	0.000813	0.0011	CcSEcCtD
Mirtazapine—Vomiting—Fludarabine—lymphatic system cancer	0.000813	0.0011	CcSEcCtD
Mirtazapine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000808	0.0011	CcSEcCtD
Mirtazapine—Rash—Fludarabine—lymphatic system cancer	0.000806	0.00109	CcSEcCtD
Mirtazapine—Dermatitis—Fludarabine—lymphatic system cancer	0.000806	0.00109	CcSEcCtD
Mirtazapine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000805	0.00109	CcSEcCtD
Mirtazapine—Pain—Bleomycin—lymphatic system cancer	0.000802	0.00109	CcSEcCtD
Mirtazapine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000801	0.00109	CcSEcCtD
Mirtazapine—Headache—Fludarabine—lymphatic system cancer	0.000801	0.00109	CcSEcCtD
Mirtazapine—Tachycardia—Carmustine—lymphatic system cancer	0.000799	0.00108	CcSEcCtD
Mirtazapine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000794	0.00108	CcSEcCtD
Mirtazapine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000794	0.00108	CcSEcCtD
Mirtazapine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000794	0.00108	CcSEcCtD
Mirtazapine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000791	0.00107	CcSEcCtD
Mirtazapine—Lethargy—Methotrexate—lymphatic system cancer	0.000787	0.00107	CcSEcCtD
Mirtazapine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000784	0.00106	CcSEcCtD
Mirtazapine—Oedema—Vincristine—lymphatic system cancer	0.000781	0.00106	CcSEcCtD
Mirtazapine—Anorexia—Carmustine—lymphatic system cancer	0.00078	0.00106	CcSEcCtD
Mirtazapine—Infection—Vincristine—lymphatic system cancer	0.000776	0.00105	CcSEcCtD
Mirtazapine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000773	0.00105	CcSEcCtD
Mirtazapine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000771	0.00105	CcSEcCtD
Mirtazapine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000767	0.00104	CcSEcCtD
Mirtazapine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000766	0.00104	CcSEcCtD
Mirtazapine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000765	0.00104	CcSEcCtD
Mirtazapine—Hypotension—Carmustine—lymphatic system cancer	0.000765	0.00104	CcSEcCtD
Mirtazapine—Oedema—Mitoxantrone—lymphatic system cancer	0.000761	0.00103	CcSEcCtD
Mirtazapine—Nausea—Fludarabine—lymphatic system cancer	0.00076	0.00103	CcSEcCtD
Mirtazapine—Infection—Mitoxantrone—lymphatic system cancer	0.000756	0.00103	CcSEcCtD
Mirtazapine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000755	0.00102	CcSEcCtD
Mirtazapine—Shock—Mitoxantrone—lymphatic system cancer	0.000749	0.00102	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000746	0.00101	CcSEcCtD
Mirtazapine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000745	0.00101	CcSEcCtD
Mirtazapine—Urticaria—Bleomycin—lymphatic system cancer	0.000745	0.00101	CcSEcCtD
Mirtazapine—Anorexia—Vincristine—lymphatic system cancer	0.000745	0.00101	CcSEcCtD
Mirtazapine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000743	0.00101	CcSEcCtD
Mirtazapine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000741	0.00101	CcSEcCtD
Mirtazapine—Insomnia—Carmustine—lymphatic system cancer	0.00074	0.001	CcSEcCtD
Mirtazapine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000739	0.001	CcSEcCtD
Mirtazapine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000736	0.000998	CcSEcCtD
Mirtazapine—Paraesthesia—Carmustine—lymphatic system cancer	0.000735	0.000997	CcSEcCtD
Mirtazapine—Mood swings—Methotrexate—lymphatic system cancer	0.000731	0.000991	CcSEcCtD
Mirtazapine—Hypotension—Vincristine—lymphatic system cancer	0.00073	0.000991	CcSEcCtD
Mirtazapine—Dyspnoea—Carmustine—lymphatic system cancer	0.00073	0.00099	CcSEcCtD
Mirtazapine—Somnolence—Carmustine—lymphatic system cancer	0.000728	0.000987	CcSEcCtD
Mirtazapine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000725	0.000984	CcSEcCtD
Mirtazapine—Ataxia—Methotrexate—lymphatic system cancer	0.000725	0.000984	CcSEcCtD
Mirtazapine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000712	0.000966	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000712	0.000966	CcSEcCtD
Mirtazapine—Decreased appetite—Carmustine—lymphatic system cancer	0.000712	0.000965	CcSEcCtD
Mirtazapine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000711	0.000965	CcSEcCtD
Mirtazapine—Insomnia—Vincristine—lymphatic system cancer	0.000707	0.000959	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000707	0.000959	CcSEcCtD
Mirtazapine—Paraesthesia—Vincristine—lymphatic system cancer	0.000702	0.000952	CcSEcCtD
Mirtazapine—Constipation—Carmustine—lymphatic system cancer	0.0007	0.00095	CcSEcCtD
Mirtazapine—Pain—Carmustine—lymphatic system cancer	0.0007	0.00095	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000695	0.000942	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000693	0.000941	CcSEcCtD
Mirtazapine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000691	0.000937	CcSEcCtD
Mirtazapine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000683	0.000927	CcSEcCtD
Mirtazapine—Decreased appetite—Vincristine—lymphatic system cancer	0.000679	0.000922	CcSEcCtD
Mirtazapine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000678	0.00092	CcSEcCtD
Mirtazapine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000677	0.000918	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000675	0.000915	CcSEcCtD
Mirtazapine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000675	0.000915	CcSEcCtD
Mirtazapine—Fatigue—Vincristine—lymphatic system cancer	0.000674	0.000914	CcSEcCtD
Mirtazapine—Asthenia—Bleomycin—lymphatic system cancer	0.000673	0.000913	CcSEcCtD
Mirtazapine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00067	0.000909	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000669	0.000908	CcSEcCtD
Mirtazapine—Pain—Vincristine—lymphatic system cancer	0.000668	0.000907	CcSEcCtD
Mirtazapine—Constipation—Vincristine—lymphatic system cancer	0.000668	0.000907	CcSEcCtD
Mirtazapine—Asthma—Methotrexate—lymphatic system cancer	0.000667	0.000905	CcSEcCtD
Mirtazapine—Pruritus—Bleomycin—lymphatic system cancer	0.000663	0.0009	CcSEcCtD
Mirtazapine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000662	0.000897	CcSEcCtD
Mirtazapine—Eosinophilia—Methotrexate—lymphatic system cancer	0.00066	0.000896	CcSEcCtD
Mirtazapine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000656	0.00089	CcSEcCtD
Mirtazapine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000654	0.000887	CcSEcCtD
Mirtazapine—Constipation—Mitoxantrone—lymphatic system cancer	0.000651	0.000883	CcSEcCtD
Mirtazapine—Pain—Mitoxantrone—lymphatic system cancer	0.000651	0.000883	CcSEcCtD
Mirtazapine—Body temperature increased—Carmustine—lymphatic system cancer	0.000647	0.000878	CcSEcCtD
Mirtazapine—Abdominal pain—Carmustine—lymphatic system cancer	0.000647	0.000878	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000639	0.000867	CcSEcCtD
Mirtazapine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000633	0.000859	CcSEcCtD
Mirtazapine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000627	0.000851	CcSEcCtD
Mirtazapine—Dysuria—Methotrexate—lymphatic system cancer	0.000623	0.000846	CcSEcCtD
Mirtazapine—Neutropenia—Methotrexate—lymphatic system cancer	0.000623	0.000846	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000622	0.000844	CcSEcCtD
Mirtazapine—Body temperature increased—Vincristine—lymphatic system cancer	0.000618	0.000838	CcSEcCtD
Mirtazapine—Abdominal pain—Vincristine—lymphatic system cancer	0.000618	0.000838	CcSEcCtD
Mirtazapine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000614	0.000833	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000609	0.000826	CcSEcCtD
Mirtazapine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000605	0.00082	CcSEcCtD
Mirtazapine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000603	0.000818	CcSEcCtD
Mirtazapine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000602	0.000816	CcSEcCtD
Mirtazapine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000602	0.000816	CcSEcCtD
Mirtazapine—Pneumonia—Methotrexate—lymphatic system cancer	0.000598	0.000811	CcSEcCtD
Mirtazapine—Vomiting—Bleomycin—lymphatic system cancer	0.000596	0.000809	CcSEcCtD
Mirtazapine—Drowsiness—Methotrexate—lymphatic system cancer	0.000594	0.000806	CcSEcCtD
Mirtazapine—Rash—Bleomycin—lymphatic system cancer	0.000591	0.000802	CcSEcCtD
Mirtazapine—Dermatitis—Bleomycin—lymphatic system cancer	0.000591	0.000801	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000589	0.0008	CcSEcCtD
Mirtazapine—Asthenia—Carmustine—lymphatic system cancer	0.000587	0.000797	CcSEcCtD
Mirtazapine—Stomatitis—Methotrexate—lymphatic system cancer	0.000579	0.000786	CcSEcCtD
Mirtazapine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000578	0.000784	CcSEcCtD
Mirtazapine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000576	0.000781	CcSEcCtD
Mirtazapine—Sweating—Methotrexate—lymphatic system cancer	0.00057	0.000773	CcSEcCtD
Mirtazapine—Haematuria—Methotrexate—lymphatic system cancer	0.000567	0.000769	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000562	0.000763	CcSEcCtD
Mirtazapine—Epistaxis—Methotrexate—lymphatic system cancer	0.000561	0.000761	CcSEcCtD
Mirtazapine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000561	0.000761	CcSEcCtD
Mirtazapine—Asthenia—Vincristine—lymphatic system cancer	0.000561	0.000761	CcSEcCtD
Mirtazapine—Diarrhoea—Carmustine—lymphatic system cancer	0.00056	0.00076	CcSEcCtD
Mirtazapine—Nausea—Bleomycin—lymphatic system cancer	0.000557	0.000756	CcSEcCtD
Mirtazapine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000555	0.000753	CcSEcCtD
Mirtazapine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000546	0.000741	CcSEcCtD
Mirtazapine—Dizziness—Carmustine—lymphatic system cancer	0.000541	0.000734	CcSEcCtD
Mirtazapine—Diarrhoea—Vincristine—lymphatic system cancer	0.000535	0.000725	CcSEcCtD
Mirtazapine—Hepatitis—Methotrexate—lymphatic system cancer	0.000534	0.000724	CcSEcCtD
Mirtazapine—Pharyngitis—Methotrexate—lymphatic system cancer	0.00053	0.000719	CcSEcCtD
Mirtazapine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000527	0.000715	CcSEcCtD
Mirtazapine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000523	0.00071	CcSEcCtD
Mirtazapine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000521	0.000706	CcSEcCtD
Mirtazapine—Vomiting—Carmustine—lymphatic system cancer	0.00052	0.000706	CcSEcCtD
Mirtazapine—Dizziness—Vincristine—lymphatic system cancer	0.000517	0.000701	CcSEcCtD
Mirtazapine—Rash—Carmustine—lymphatic system cancer	0.000516	0.0007	CcSEcCtD
Mirtazapine—Dermatitis—Carmustine—lymphatic system cancer	0.000516	0.0007	CcSEcCtD
Mirtazapine—Headache—Carmustine—lymphatic system cancer	0.000513	0.000696	CcSEcCtD
Mirtazapine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000505	0.000685	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—lymphatic system cancer	0.000499	0.000677	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—lymphatic system cancer	0.000498	0.000675	CcSEcCtD
Mirtazapine—Vomiting—Vincristine—lymphatic system cancer	0.000497	0.000674	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000495	0.000672	CcSEcCtD
Mirtazapine—Rash—Vincristine—lymphatic system cancer	0.000493	0.000668	CcSEcCtD
Mirtazapine—Dermatitis—Vincristine—lymphatic system cancer	0.000492	0.000668	CcSEcCtD
Mirtazapine—Headache—Vincristine—lymphatic system cancer	0.00049	0.000664	CcSEcCtD
Mirtazapine—Nausea—Carmustine—lymphatic system cancer	0.000486	0.00066	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—lymphatic system cancer	0.000484	0.000657	CcSEcCtD
Mirtazapine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000484	0.000656	CcSEcCtD
Mirtazapine—Rash—Mitoxantrone—lymphatic system cancer	0.00048	0.000651	CcSEcCtD
Mirtazapine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000479	0.00065	CcSEcCtD
Mirtazapine—Chills—Methotrexate—lymphatic system cancer	0.000479	0.00065	CcSEcCtD
Mirtazapine—Headache—Mitoxantrone—lymphatic system cancer	0.000477	0.000647	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—lymphatic system cancer	0.000472	0.00064	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—lymphatic system cancer	0.000468	0.000634	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—lymphatic system cancer	0.000465	0.00063	CcSEcCtD
Mirtazapine—Nausea—Vincristine—lymphatic system cancer	0.000464	0.00063	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000455	0.000617	CcSEcCtD
Mirtazapine—Nausea—Mitoxantrone—lymphatic system cancer	0.000452	0.000613	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—lymphatic system cancer	0.000449	0.00061	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000431	0.000585	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—lymphatic system cancer	0.000429	0.000583	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—lymphatic system cancer	0.000419	0.000568	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—lymphatic system cancer	0.000417	0.000566	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—lymphatic system cancer	0.000416	0.000564	CcSEcCtD
Mirtazapine—Cough—Methotrexate—lymphatic system cancer	0.000405	0.00055	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—lymphatic system cancer	0.000403	0.000546	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—lymphatic system cancer	0.000396	0.000537	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—lymphatic system cancer	0.000396	0.000537	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—lymphatic system cancer	0.000396	0.000537	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000393	0.000533	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—lymphatic system cancer	0.000391	0.00053	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—lymphatic system cancer	0.000382	0.000519	CcSEcCtD
Mirtazapine—Infection—Methotrexate—lymphatic system cancer	0.000377	0.000511	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000372	0.000504	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000371	0.000504	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—lymphatic system cancer	0.000368	0.0005	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000367	0.000497	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—lymphatic system cancer	0.000361	0.00049	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—lymphatic system cancer	0.000354	0.000481	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000345	0.000469	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—lymphatic system cancer	0.000343	0.000465	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00034	0.000462	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000338	0.000459	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—lymphatic system cancer	0.000337	0.000457	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000334	0.000453	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00033	0.000447	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000327	0.000444	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—lymphatic system cancer	0.000327	0.000443	CcSEcCtD
Mirtazapine—Pain—Methotrexate—lymphatic system cancer	0.000324	0.00044	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000312	0.000424	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00031	0.000421	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—lymphatic system cancer	0.000301	0.000409	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—lymphatic system cancer	0.0003	0.000407	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—lymphatic system cancer	0.0003	0.000407	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000279	0.000379	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—lymphatic system cancer	0.000272	0.000369	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—lymphatic system cancer	0.000268	0.000364	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000259	0.000352	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—lymphatic system cancer	0.000251	0.00034	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—lymphatic system cancer	0.000241	0.000327	CcSEcCtD
Mirtazapine—Rash—Methotrexate—lymphatic system cancer	0.000239	0.000324	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—lymphatic system cancer	0.000239	0.000324	CcSEcCtD
Mirtazapine—Headache—Methotrexate—lymphatic system cancer	0.000238	0.000322	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—lymphatic system cancer	0.000225	0.000306	CcSEcCtD
